Annual Reports

Browse

Browsing Annual Reports by Subject "HIFAR Reactor"

Now showing 1 - 7 of 7
  • Thumbnail Image
    Item
    ANSTO annual report 1999-00.
    (Australian Nuclear Science and Technology Organisation, 2000)
    The period from July 1999 to June 2000 has, yet again, been both exciting and challenging. Our most important project is the Replacement Research Reactor Project - important not only for the future of the Organisation but also for the maintenance and development of a range of scientific and technological expertise that will underpin Australia's socio-economic development in the knowledge era. In August 1999 this project received unanimous approval from the bipartisan Public Works Committee. ANSTO immediately released the Request for Tender to the four prequalified vendors. All vendors, in alliance or partnership with Australian engineering companies, submitted proposals on the closing date of January 3rd, 2000. These proposals were reviewed and evaluated by internal and external experts, culminating in the final recommendation that INVAP SE, in alliance with John Holland Construction and Engineering Pty Ltd and Evans Deakin Industries Limited, be awarded the contract for the detailed engineering design, construction and commissioning of the replacement research reactor at the Lucas Heights Science and Technology Centre. After obtaining all relevant approvals, the contract was signed early in July and marked by a ceremony involving many of the people who had contributed to the process. The tender selection process was audited from start to finish and the relevant audit and review reports posted on ANSTO's website as part of our community advice. As this Annual Report goes to press the project is well underway. ANSTO staff are to be commended for their professionalism and dedication throughout the replacement research reactor project to date. They have worked tirelessly and met all major milestones under their control. It was heartening to learn that our comprehensive and independently audited consultation program during the environmental assessment phase of the replacement research reactor project was acclaimed by two awards from the Public Relations Institute of Australia. All of us at ANSTO appreciate the very considerable support and encouragement we have received from government, individuals, companies and professional societies across the science, engineering, medical and policy spectra. We look forward to working with our stakeholders to ensure that the scientific instruments developed for the various beamlines on the reactor are capable of delivering world class outcomes. During the past year current ANSTO's core nuclear facilities have been in strong demand. Staff and students from universities across Australia have accessed the facilities through AINSE, there being around 160 AINSE-supported university projects in the past year. ANSTO staff not only facilitate the execution of these projects but also undertake research to underpin other important elements of ANSTO's mission. Such projects are frequently carried out in collaboration with national and international teaming partners.
  • Thumbnail Image
    Item
    ANSTO annual report 2000-01
    (Australian Nuclear Science and Technology Organisation, 2001) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation. It has a staff of approximately 800 and is located at the Lucas Heights Science and Technology Centre, some 40 km south west of Sydney city centre. The science and technology centre occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO operates Australia’s only nuclear reactor, the research reactor HIFAR (which stands for High Flux Australian Reactor). The reactor is used to produce radioactive products for use in medicine and industry. It is also used extensively as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. The facility is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, an inner west suburb of Sydney. ANSTO provides the broad range of technical expertise needed to support Australia’s nuclear interests. It advises the Commonwealth Government on issues associated with the nuclear fuel cycle and the operation of nuclear facilities and it supports industry through the development and application of nuclear science based technology and associated capabilities. ANSTO organises its activities under six core business areas. Safety and environmental protection arrangements at ANSTO facilities are reported against separately. Further information about the organisation is available on ANSTO’s web site at www.ansto.gov.au.
  • Thumbnail Image
    Item
    ANSTO annual report 2001-02
    (Australian Nuclear Science and Technology Organisation, 2002) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. It does so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. This is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, close to Sydney’s central business district. ANSTO has a salaried staff of approximately 850. Its main site is located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district. The LHSTC occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2002-03
    (Australian Nuclear Science and Technology Organisation, 2003) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development (R&D) organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron (NMC), an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2003-04
    (Australian Nuclear Science and Technology Organisation, 2004)
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor, HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2004-05
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its final stages of construction. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2005-06
    (Australian Nuclear Science and Technology Organisation, 2006) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its commissioning phase. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.